| The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis ST Wilkinson, ED Ballard, MH Bloch, SJ Mathew, JW Murrough, A Feder, ... American journal of psychiatry 175 (2), 150-158, 2018 | 646 | 2018 |
| Gone to pot–a review of the association between cannabis and psychosis R Radhakrishnan, ST Wilkinson, DC D’Souza Frontiers in psychiatry 5, 54, 2014 | 472 | 2014 |
| Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) M Fava, MP Freeman, M Flynn, H Judge, BB Hoeppner, C Cusin, ... Molecular psychiatry 25 (7), 1592-1603, 2020 | 377 | 2020 |
| Marijuana legalization: impact on physicians and public health ST Wilkinson, S Yarnell, R Radhakrishnan, SA Ball, DC D'Souza Annual review of medicine 67 (1), 453-466, 2016 | 259 | 2016 |
| Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression—TRANSFORM-3 R Ochs-Ross, EJ Daly, Y Zhang, R Lane, P Lim, RL Morrison, D Hough, ... The American Journal of Geriatric Psychiatry 28 (2), 121-141, 2020 | 231 | 2020 |
| Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2) E Wajs, L Aluisio, R Holder, EJ Daly, R Lane, P Lim, JE George, ... The Journal of clinical psychiatry 81 (3), 10773, 2020 | 221 | 2020 |
| 20-year trends in the pharmacologic treatment of bipolar disorder by psychiatrists in outpatient care settings TG Rhee, M Olfson, AA Nierenberg, ST Wilkinson American Journal of Psychiatry 177 (8), 706-715, 2020 | 183 | 2020 |
| Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder ST Wilkinson, E Stefanovics, RA Rosenheck The Journal of clinical psychiatry 76 (9), 11266, 2015 | 179 | 2015 |
| A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter … ST Wilkinson, G Sanacora Drug discovery today 24 (2), 606-615, 2019 | 151 | 2019 |
| Impact of cannabis use on the development of psychotic disorders ST Wilkinson, R Radhakrishnan, DC D’Souza Current addiction reports 1, 115-128, 2014 | 150 | 2014 |
| Cognitive behavior therapy may sustain antidepressant effects of intravenous ketamine in treatment-resistant depression ST Wilkinson, DS Wright, MK Fasula, L Fenton, M Griepp, RB Ostroff, ... Psychotherapy and Psychosomatics 86 (3), 162-167, 2017 | 126 | 2017 |
| A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders ST Wilkinson, M Toprak, MS Turner, SP Levine, RB Katz, G Sanacora American Journal of Psychiatry 174 (7), 695-696, 2017 | 121 | 2017 |
| Ketamine versus ECT for nonpsychotic treatment-resistant major depression A Anand, SJ Mathew, G Sanacora, JW Murrough, FS Goes, M Altinay, ... New England Journal of Medicine 388 (25), 2315-2325, 2023 | 118 | 2023 |
| A systematic review of the evidence for medical marijuana in psychiatric indications ST Wilkinson, R Radhakrishnan The Journal of clinical psychiatry 77 (8), 11477, 2016 | 106 | 2016 |
| Identifying recipients of electroconvulsive therapy: data from privately insured Americans ST Wilkinson, E Agbese, DL Leslie, RA Rosenheck Psychiatric services 69 (5), 542-548, 2018 | 100 | 2018 |
| Hippocampal volume changes following electroconvulsive therapy: a systematic review and meta-analysis ST Wilkinson, G Sanacora, MH Bloch Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2 (4), 327-335, 2017 | 96 | 2017 |
| Problems with the medicalization of marijuana ST Wilkinson, DC D’Souza Jama 311 (23), 2377-2378, 2014 | 76 | 2014 |
| Efficacy and safety of ketamine vs electroconvulsive therapy among patients with major depressive episode: a systematic review and meta-analysis TG Rhee, SR Shim, BP Forester, AA Nierenberg, RS McIntyre, ... JAMA psychiatry 79 (12), 1162-1172, 2022 | 70 | 2022 |
| Acute and longer-term outcomes using ketamine as a clinical treatment at the Yale Psychiatric Hospital ST Wilkinson, RB Katz, M Toprak, R Webler, RB Ostroff, G Sanacora The Journal of clinical psychiatry 79 (4), 10099, 2018 | 70 | 2018 |
| Leveraging neuroplasticity to enhance adaptive learning: the potential for synergistic somatic-behavioral treatment combinations to improve clinical outcomes in depression ST Wilkinson, PE Holtzheimer, S Gao, DS Kirwin, RB Price Biological psychiatry 85 (6), 454-465, 2019 | 69 | 2019 |
